Correction: New clinical application prospects of artemisinin and its derivatives: a scoping review

Yangmu Huang, Yang Yang, Guangqi Liu, Ming XuInfectious 2024 · DOI

Introduction

This article serves as a formal correction to the scoping review titled "New clinical application prospects of artemisinin and its derivatives: a scoping review," which was originally published in the journal Infectious Diseases of Poverty in 2023. The purpose of this notice is to rectify critical errors in data visualization labeling and to update the authorship and contribution records, ensuring the integrity and accuracy of the scientific literature.

Background and Context

Artemisinin and its derivatives are globally recognized as the cornerstone of modern malaria treatment. However, emerging research has increasingly explored their potential therapeutic applications in other medical fields, including oncology, immunology, and the treatment of various parasitic infections. The original scoping review aimed to map this expanding clinical landscape, providing a comprehensive overview of the research status across different disease domains.

To synthesize this vast amount of evidence, the authors employed sophisticated visualization techniques, specifically chord-style diagrams (often referred to as Circos-style plots). These diagrams used semicircles to represent two distinct data dimensions: the upper semicircle categorized research results (such as efficacy and safety), while the lower semicircle represented specific disease fields. The connections between these semicircles, represented as "strings," were weighted by width to indicate the volume of evidence (number of studies) for each specific application.

Correction of Data Visualization

A significant error was identified in the legend for Figure 3c, which is central to interpreting the research outcomes of artemisinin derivatives. In the original publication, the color-coding used to distinguish between different clinical results was mislabeled or swapped in the text.

The corrected legend for Figure 3c is as follows:

  • Pink: Represents "Safe" results.
  • Green: Represents "Effective" results.
  • Yellow: Represents "Invalid" results.

This correction is vital for researchers and clinicians using the review to identify which non-malarial applications of artemisinin show the most clinical promise. Without this clarification, the visual data could lead to a fundamental misunderstanding of the success or failure of artemisinin in various clinical contexts.

Additionally, the authors clarified a note regarding Figure 3b, highlighting that the width of the connections reflects an "excessive number of studies on schistosomiasis control," which dominates the current research landscape for artemisinin beyond malaria.

Updates to Authorship and Contributions

Beyond the technical data corrections, this notice addresses an administrative error regarding the study's authorship.

  1. Author Removal: Dan Hu has been removed from the author list due to personal reasons.
  2. Updated Contributions: The author contribution statement has been revised to accurately reflect the work performed by the remaining team members:
  3. Yangmu Huang (YH): Conceived the research proposal and provided oversight.
  4. Yang Yang (YY) and Geng Li (GL): Conducted the primary literature review and drafted the manuscript. YY and YH are designated as co-first authors.
  5. Mei Xiao (MX): Contributed to the review and editing of the final manuscript.

Conclusion

The accuracy of data visualization and the transparency of authorship are fundamental to the scientific process. By correcting the legend of Figure 3 and updating the contributor list, this notice ensures that the scoping review remains a reliable resource for the global research community. The findings of the original review—highlighting the diverse and complex clinical prospects of artemisinin derivatives—remain a significant contribution to the field of infectious diseases and beyond.

Note: This mini-paper is based on the formal correction notice published in Infectious Diseases of Poverty (2023).

Summary updated

BibTeX
@inproceedings{huang2024correction,
  author = {Yangmu Huang and Yang Yang and Guangqi Liu and Ming Xu},
  title = {{Correction: New clinical application prospects of artemisinin and its derivatives: a scoping review}},
  booktitle = {Infectious},
  year = {2024},
  doi = {10.1186/s40249-024-01180-w},
}
Figure